Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamdy A Azim

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of the Egyptian National Cancer Institute|August 30, 2012
Bone metastasis in breast cancer: the story of RANK-ligandHamdy A Azim, Nermine S Kamal, Hatem A Azim
Journal of Thoracic Disease|July 3, 2013
Bisphosphonates in the adjuvant treatment of young women with breast cancer: the estrogen rich is a poor candidate!Hamdy A Azim, Nermine S Kamal, Rafaat A Malak
The Breast Journal|December 25, 2019
Personalized treatment in metastatic triple-negative breast cancer: The outlook in 2020Hamdy A Azim, Marwan Ghosn, Karima Oualla, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
The process of NCCN guidelines adaptation to the Middle East and North Africa regionAbdul-Rahman Jazieh, Hamdy A Azim, Joan McClure, et al.
JCO Global Oncology|September 3, 2025
Social Determinants Associated With the Advanced-Stage Diagnosis of Breast CancerMadonna A Fekry, Loay Kassem, Justin C Yang, et al.
The Breast Journal|November 12, 2019
Understanding the benefits and challenges of first-line cyclin-dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal womenHamdy A Azim, Shaheenah Dawood, Nagi El-Saghir, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 7, 2025
Homologous Recombination Deficiency Testing in Women With Ovarian Cancer: An Egyptian Multicentre StudyKyrillus S Shohdy, Loay Kassem, Boules Gabriel, et al.
Current Problems in Cancer|June 13, 2020
Adjuvant ovarian function suppression and tamoxifen in premenopausal breast cancer patients: A meta-analysisHamdy A Azim, Kyrillus S Shohdy, David F Kaldas, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 18, 2022
Programmed death-ligand 1 (PD-L1) expression predicts response to neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysisHamdy A Azim, Kyrillus S Shohdy, Hagar Elghazawy, et al.
International Journal of Surgery (London, England)|February 3, 2016
TNMF versus TNM in staging of colorectal cancerAhmed Farag Ahmed Farag, Mohamed Yehia Elbarmelgi, Hamdy A Azim, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of the Egyptian National Cancer Institute|August 30, 2012
Bone metastasis in breast cancer: the story of RANK-ligandHamdy A Azim, Nermine S Kamal, Hatem A Azim
Journal of Thoracic Disease|July 3, 2013
Bisphosphonates in the adjuvant treatment of young women with breast cancer: the estrogen rich is a poor candidate!Hamdy A Azim, Nermine S Kamal, Rafaat A Malak
The Breast Journal|December 25, 2019
Personalized treatment in metastatic triple-negative breast cancer: The outlook in 2020Hamdy A Azim, Marwan Ghosn, Karima Oualla, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
The process of NCCN guidelines adaptation to the Middle East and North Africa regionAbdul-Rahman Jazieh, Hamdy A Azim, Joan McClure, et al.
JCO Global Oncology|September 3, 2025
Social Determinants Associated With the Advanced-Stage Diagnosis of Breast CancerMadonna A Fekry, Loay Kassem, Justin C Yang, et al.
The Breast Journal|November 12, 2019
Understanding the benefits and challenges of first-line cyclin-dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal womenHamdy A Azim, Shaheenah Dawood, Nagi El-Saghir, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 7, 2025
Homologous Recombination Deficiency Testing in Women With Ovarian Cancer: An Egyptian Multicentre StudyKyrillus S Shohdy, Loay Kassem, Boules Gabriel, et al.
Current Problems in Cancer|June 13, 2020
Adjuvant ovarian function suppression and tamoxifen in premenopausal breast cancer patients: A meta-analysisHamdy A Azim, Kyrillus S Shohdy, David F Kaldas, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 18, 2022
Programmed death-ligand 1 (PD-L1) expression predicts response to neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysisHamdy A Azim, Kyrillus S Shohdy, Hagar Elghazawy, et al.
International Journal of Surgery (London, England)|February 3, 2016
TNMF versus TNM in staging of colorectal cancerAhmed Farag Ahmed Farag, Mohamed Yehia Elbarmelgi, Hamdy A Azim, et al.
Pageof 4